{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:48:11Z","timestamp":1792273691344,"version":"4.4.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100017695","name":"Health Commission of Hunan Province","doi-asserted-by":"publisher","award":["C202304078073"],"award-info":[{"award-number":["C202304078073"]}],"id":[{"id":"10.13039\/100017695","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00198-026-08049-8","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T05:53:18Z","timestamp":1779256398000},"page":"2099-2107","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of denosumab versus zoledronate on preventing secondary osteoporotic vertebral compression fracture: a prospective study with 2-year follow-up"],"prefix":"10.1007","volume":"37","author":[{"given":"Nuo","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"issue":"9668","key":"8049_CR1","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/S0140-6736(09)60010-6","volume":"373","author":"D Wardlaw","year":"2009","unstructured":"Wardlaw D et al (2009) Efficacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomised controlled trial. Lancet 373(9668):1016\u201324","journal-title":"Lancet"},{"issue":"2","key":"8049_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/neuros\/nyaa435","volume":"88","author":"P Chiu","year":"2021","unstructured":"Chiu P et al (2021) A retrospective analysis in 1347 patients undergoing cement augmentation for osteoporotic vertebral compression fracture: is the sandwich vertebra at a higher risk of further fracture? Neurosurgery 88(2):1\u20137","journal-title":"Neurosurgery"},{"issue":"25","key":"8049_CR3","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1097\/BRS.0000000000000025","volume":"38","author":"B Frankel","year":"2013","unstructured":"Frankel B et al (2013) Natural history and risk factors for adjacent vertebral fractures in the Fracture Intervention Trial. Spine (Phila Pa 1976) 38(25):2201\u20137","journal-title":"Spine (Phila Pa 1976)"},{"key":"8049_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-025-07813-6","author":"K Wei-Han","year":"2025","unstructured":"Wei-Han K et al (2025) Romosozumab mitigates progression from radiological to symptomatic adjacent-level fractures compared to Teriparatide. Osteoporos Int. https:\/\/doi.org\/10.1007\/s00198-025-07813-6","journal-title":"Osteoporos Int"},{"issue":"5","key":"8049_CR5","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1210\/jc.2019-00192","volume":"104","author":"P Barrionuevo","year":"2019","unstructured":"Barrionuevo P et al (2019) Efficacy of pharmacological therapies for the prevention of fractures in postmenopausal women: a network meta-analysis. J Clin Endocrinol Metab 104(5):1623\u20131630","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"8049_CR6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3122\/jabfm.2022.220099R1","volume":"36","author":"KA Thal","year":"2023","unstructured":"Thal KA et al (2023) Denosumab versus bisphosphonates for reducing fractures in postmenopausal women with osteoporosis: a meta-analysis. J Am Board Fam Med 36(1):175\u2013185","journal-title":"J Am Board Fam Med"},{"issue":"8","key":"8049_CR7","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1210\/jc.2016-1801","volume":"101","author":"PD Miller","year":"2016","unstructured":"Miller PD et al (2016) Denosumab or Zoledronic acid in postmenopausal women with osteoporosis previously treated with oral bisphosphonates. J Clin Endocrinol Metab 101(8):3163\u20133170","journal-title":"J Clin Endocrinol Metab"},{"key":"8049_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s13018-018-0865-3","author":"J Wu","year":"2018","unstructured":"Wu J et al (2018) Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis. J Orthop Surg Res. https:\/\/doi.org\/10.1186\/s13018-018-0865-3","journal-title":"J Orthop Surg Res"},{"issue":"8","key":"8049_CR9","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1056\/NEJMoa0809493","volume":"361","author":"SR Cummings","year":"2009","unstructured":"Cummings SR et al (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361(8):756\u201365","journal-title":"N Engl J Med"},{"issue":"18","key":"8049_CR10","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1056\/NEJMoa067312","volume":"356","author":"DM B","year":"2007","unstructured":"B DM et al (2007) Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356(18):1809\u201322","journal-title":"N Engl J Med"},{"issue":"4","key":"8049_CR11","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1007\/s00198-015-3398-1","volume":"27","author":"F Chen","year":"2015","unstructured":"Chen F et al (2015) Effects of zoledronic acid on bone fusion in osteoporotic patients after lumbar fusion. Osteoporos Int 27(4):1469\u20131476","journal-title":"Osteoporos Int"},{"issue":"0","key":"8049_CR12","doi-asserted-by":"publisher","first-page":"e1310","DOI":"10.1016\/j.wneu.2022.09.021","volume":"167","author":"Y Xiong","year":"2022","unstructured":"Xiong Y et al (2022) Effect of teriparatide versus zoledronate on posterior lumbar interbody fusion in postmenopausal women with osteoporosis. World Neurosurg 167(0):e1310\u2013e1316","journal-title":"World Neurosurg"},{"key":"8049_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s13018-025-06040-3","author":"P Su","year":"2025","unstructured":"Su P et al (2025) Effectiveness of anabolic and anti-resorptive agents for preventing postmenopausal osteoporosis fractures: a systematic review and network meta-analysis. J Orthop Surg Res. https:\/\/doi.org\/10.1186\/s13018-025-06040-3","journal-title":"J Orthop Surg Res"},{"issue":"4","key":"8049_CR14","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1002\/jbmr.3641","volume":"34","author":"ML Bouxsein","year":"2019","unstructured":"Bouxsein ML et al (2019) Change in bone density and reduction in fracture risk: a meta-regression of published trials. J Bone Miner Res 34(4):632\u2013642","journal-title":"J Bone Miner Res"},{"issue":"3","key":"8049_CR15","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1001\/jama.285.3.320","volume":"285","author":"R Lindsay","year":"2001","unstructured":"Lindsay R (2001) Risk of new vertebral fracture in the year following a fracture. JAMA 285(3):320\u2013323","journal-title":"JAMA"},{"issue":"1","key":"8049_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/2192568219834899","volume":"10","author":"M Morozumi","year":"2020","unstructured":"Morozumi M et al (2020) A study of risk factors for early-onset adjacent vertebral fractures after kyphoplasty. Global Spine J 10(1):13\u201320","journal-title":"Global Spine J"},{"issue":"9041","key":"8049_CR17","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","volume":"348","author":"DM Black","year":"1996","unstructured":"Black DM et al (1996) Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348(9041):1535\u20131541","journal-title":"Lancet"},{"issue":"6","key":"8049_CR18","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.clinthera.2020.04.011","volume":"42","author":"FC Kao","year":"2020","unstructured":"Kao FC et al (2020) Effects of injected antiosteoporotic medication versus oral bisphosphonates on rates of repeated vertebroplasty or kyphoplasty. Clin Ther 42(6):1087-1098 e2","journal-title":"Clin Ther"},{"issue":"7","key":"8049_CR19","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1001\/jama.2016.11136","volume":"316","author":"PD Miller","year":"2016","unstructured":"Miller PD et al (2016) Effect of abaloparatide vs placebo on new vertebral fractures in postmenopausal women with osteoporosis: a randomized clinical trial. JAMA 316(7):722\u201333","journal-title":"JAMA"},{"issue":"5","key":"8049_CR20","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1007\/s00198-011-1730-y","volume":"23","author":"YY Tseng","year":"2012","unstructured":"Tseng YY et al (2012) Prospective comparison of the therapeutic effect of teriparatide with that of combined vertebroplasty with antiresorptive agents for the treatment of new-onset adjacent vertebral compression fracture after percutaneous vertebroplasty. Osteoporos Int 23(5):1613\u20131622","journal-title":"Osteoporos Int"},{"issue":"1","key":"8049_CR21","doi-asserted-by":"publisher","first-page":"ITC1","DOI":"10.7326\/AITC202401160","volume":"177","author":"KE Ensrud","year":"2024","unstructured":"Ensrud KE, Crandall CJ (2024) Osteoporosis. Ann Intern Med 177(1):ITC1\u2013ITC16","journal-title":"Ann Intern Med"},{"issue":"13","key":"8049_CR22","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1056\/NEJMoa031975","volume":"349","author":"DM Black","year":"2003","unstructured":"Black DM et al (2003) The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med 349(13):1207\u201315","journal-title":"N Engl J Med"},{"issue":"5","key":"8049_CR23","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/jbmr.2496","volume":"30","author":"E Seeman","year":"2015","unstructured":"Seeman E, Martin TJ (2015) Co-administration of antiresorptive and anabolic agents: a missed opportunity. J Bone Miner Res 30(5):753\u2013764","journal-title":"J Bone Miner Res"},{"issue":"1","key":"8049_CR24","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11914-009-0004-5","volume":"7","author":"PD M","year":"2009","unstructured":"M PD (2009) Denosumab: anti-RANKL antibody. Curr Osteoporos Rep 7(1):18\u201322","journal-title":"Curr Osteoporos Rep"},{"issue":"1","key":"8049_CR25","first-page":"37","volume":"17","author":"M Kiyomi","year":"2007","unstructured":"Kiyomi M, Kazuo I (2007) Therapeutic agents for disorders of bone and calcium metabolism\u2013Denosumab, a fully human monoclocal antibody-targeting RANKL as a therapy for cancer-induced bone diseases. Clin Calcium 17(1):37\u201346","journal-title":"Clin Calcium"},{"issue":"4","key":"8049_CR26","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.bone.2010.11.020","volume":"48","author":"R Baron","year":"2011","unstructured":"Baron R, Ferrari S, Russell RGG (2011) Denosumab and bisphosphonates: different mechanisms of action and effects. Bone 48(4):677\u2013692","journal-title":"Bone"},{"key":"8049_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bonr.2020.100728","volume":"13","author":"S Akhter","year":"2020","unstructured":"Akhter S et al (2020) The efficacy of teriparatide on lumbar spine bone mineral density, vertebral fracture incidence and pain in post-menopausal osteoporotic patients: a systematic review and meta-analysis. Bone Rep 13:100728","journal-title":"Bone Rep"},{"issue":"12","key":"8049_CR28","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.2106\/JBJS.15.00425","volume":"98","author":"R Mattie","year":"2016","unstructured":"Mattie R et al (2016) Comparing percutaneous vertebroplasty and conservative therapy for treating osteoporotic compression fractures in the thoracic and lumbar spine: a systematic review and meta-analysis. J Bone Joint Surg Am 98(12):1041\u201351","journal-title":"J Bone Joint Surg Am"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-026-08049-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-026-08049-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-026-08049-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:07:16Z","timestamp":1792271236000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-026-08049-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["8049"],"URL":"https:\/\/doi.org\/10.1007\/s00198-026-08049-8","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"1 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of the Second Xiangya Hospital of Central South University. Written informed consent was obtained from all participants prior to enrollment.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None","order":2,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}